Literature DB >> 3594715

The effect of abolition of the endogenous corticosteroid rhythm on the circadian variation in methotrexate toxicity in the rat.

J English, G W Aherne, J Arendt, V Marks.   

Abstract

Monitoring of indices of haematological, renal and hepatic toxicity in rats after a single i.v. bolus of methotrexate has shown that they vary with the time of day at which the drug is administered. Maximum toxicity occurs after administration at 0600 h. Further experimentation has shown that the amount of corticosteroid present in the blood has a profound effect on the toxicity of methotrexate in the rat. If the endogenous production of corticosterone is suppressed by treatment with dexamethasone the toxicity of methotrexate is markedly increased at whatever clock time it is administered. However, if constantly high plasma levels are achieved by giving supplementary corticosterone methotrexate toxicity is diminished regardless of what time it is given. Since the timing of maximum methotrexate toxicity corresponds to the circadian nadir of endogenous plasma corticosterone concentration in the rat the possibility that it might be related to corticosterone production must be considered. Whether this phenomenon occurs in man and has any clinical relevance has yet to be investigated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594715     DOI: 10.1007/bf00261474

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  17 in total

1.  A rapid and precise method for the determination of urea.

Authors:  J K FAWCETT; J E SCOTT
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

2.  [Diurnal variations evidence of glomerular filtration in the rat (author's transl)].

Authors:  J Cambar; F Lemoigne; C Toussaint
Journal:  Experientia       Date:  1979-12-15

3.  Effect of biological time on the determination of the LD50 of 5-fluorouracil in mice.

Authors:  E R Burns; S S Beland
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

4.  Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.

Authors:  E R Burns; L E Scheving
Journal:  Chronobiologia       Date:  1980 Jan-Mar

5.  Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening.

Authors:  G E Rivard; C Infante-Rivard; C Hoyoux; J Champagne
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

6.  Melatonin protects rats from injurious effects of a glucocorticoid, dexamethasone.

Authors:  W Mori; H Aoyama; N Mori
Journal:  Jpn J Exp Med       Date:  1984-12

7.  Diurnal variation in the intestinal toxicity of 5-fluorouracil in the rat.

Authors:  M L Gardner; J A Plumb
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

8.  The effect of timing of a single injection on the toxicity of methotrexate in the rat.

Authors:  J English; G W Aherne; V Marks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Human epidermal cell proliferation with regard to circadian variation of plasma cortisol.

Authors:  H Schell; O P Hornstein; W Schwarz
Journal:  Dermatologica       Date:  1980

10.  Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.

Authors:  R Shepherd; K R Harrap
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

View more
  3 in total

1.  Circadian pharmacokinetics of methotrexate.

Authors:  B A Robinson; E J Begg; B M Colls; G M Jeffery; J R Sharman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study.

Authors:  Shingo Itai; Yukio Suga; Yusuke Hara; Kouji Izumi; Yuji Maeda; Yasuhide Kitagawa; Junko Ishizaki; Tsutomu Shimada; Atsushi Mizokami; Yoshimichi Sai
Journal:  J Pharm Health Care Sci       Date:  2017-01-11

Review 3.  An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.

Authors:  Ankit Das; Niraja Ranadive; Manas Kinra; Madhavan Nampoothiri; Devinder Arora; Jayesh Mudgal
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.